190 related articles for article (PubMed ID: 28565743)
1. [Distribution of donor-specific aKIR after unrelated allogeneic hematopoietic stem cell transplantation].
Zhang HH; He J; Bao XJ; Hu X; Wang M; Zhang J; Wu XJ
Zhonghua Xue Ye Xue Za Zhi; 2017 May; 38(5):421-426. PubMed ID: 28565743
[No Abstract] [Full Text] [Related]
2. Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation.
Sahin U; Dalva K; Gungor F; Ustun C; Beksac M
Ann Hematol; 2018 Jun; 97(6):1027-1039. PubMed ID: 29549412
[TBL] [Abstract][Full Text] [Related]
3. Positive association of Bx genotype, KIR2L5, KIR2DS5 and full-length KIR2DS4 with the risk of meningioma.
Barani S; Taghipour M; Ghaderi A
Immunobiology; 2020 Mar; 225(2):151900. PubMed ID: 31899050
[TBL] [Abstract][Full Text] [Related]
4. Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires.
Crum KA; Logue SE; Curran MD; Middleton D
Tissue Antigens; 2000 Oct; 56(4):313-26. PubMed ID: 11098931
[TBL] [Abstract][Full Text] [Related]
5. Dynamic mRNA expression of donor-derived activating KIR genes and their significant effects on clinical outcome after haematopoietic stem cell transplantation.
Li Y; Wang T; Hu X; Zhang H; Bao X; Wu D; He J
Clin Exp Immunol; 2021 Sep; 205(3):417-428. PubMed ID: 34085290
[TBL] [Abstract][Full Text] [Related]
6. [Immune reconstruct regularity profile of KIR2DL1 and KIR3DL1 in unrelated-donor allogeneic hematopoietic stem cell transplantation].
Hu X; He J; Zhang HH; Bao XJ; Wang M; Zhang J; Cen JN; Wu XJ; Yang XJ
Zhonghua Xue Ye Xue Za Zhi; 2017 Aug; 38(8):667-672. PubMed ID: 28954344
[No Abstract] [Full Text] [Related]
7. Study of KIR gene expression at the mRNA level in specific donor-derived NK cells after allogeneic HSCT.
Li Y; Wang T; Hu X; Zhang H; Chen L; Bao X; He J
Immunogenetics; 2020 Apr; 72(3):135-141. PubMed ID: 31900503
[TBL] [Abstract][Full Text] [Related]
8. The impact of donor and recipient KIR genes and KIR ligands on the occurrence of acute graft-versus-host disease and graft survival after HLA-identical sibling hematopoietic stem cell transplantation.
Hoseinian SA; Jafari D; Mahmoodi M; Alimoghaddam K; Ostadali M; Talebzadeh Bonakdar A; Foma AM; Yekaninejad MS; Amirzargar AA
Turk J Med Sci; 2018 Aug; 48(4):794-804. PubMed ID: 30119155
[TBL] [Abstract][Full Text] [Related]
9. Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.
Tajik N; Shahsavar F; Nasiri M; Radjabzadeh MF
Int J Immunogenet; 2010 Jun; 37(3):159-68. PubMed ID: 20193031
[TBL] [Abstract][Full Text] [Related]
10. [Influence of donor activating or inhibitory KIR on prognosis of unmanipulated allogeneic hematopoietic stem cell transplantation].
Liang ZY; Ren HY; Cen XN; Qiu ZX; Wang LH; Ou JP; Li Y; Wang MJ; Wang WS; Xu WL; Dong YJ; Yin Y; Sun YH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):155-60. PubMed ID: 23484711
[TBL] [Abstract][Full Text] [Related]
11. [Study on the behavior of NK cell KIRs of donor/recipient pairs in HLA matched unrelated allo-HSCT].
Bao XJ; He J; Chen ZX; Wu DP; Yao L; Yuan XN; Cen JN; Qiu QC; Di WY; Zhang H; Zhang J; Zhou XH; Xu HX
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):510-3. PubMed ID: 18078124
[TBL] [Abstract][Full Text] [Related]
12. [Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].
Dou LP; DA WM; Zhao DD; Wang C; Lu XC; Kang HY; Yan P; Wang FF; Zhu HY; Li HH; Gao CJ; Yu L
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3111-4. PubMed ID: 18269867
[TBL] [Abstract][Full Text] [Related]
13. [Killer immunoglobulin-like receptor gene genotype and expression pattern in healthy people].
Dou LP; DA WM; Huang WR; Li HH; Zhao Y; Wang QS; Gao CJ; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):132-5. PubMed ID: 20137133
[TBL] [Abstract][Full Text] [Related]
14. HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.
Venstrom JM; Pittari G; Gooley TA; Chewning JH; Spellman S; Haagenson M; Gallagher MM; Malkki M; Petersdorf E; Dupont B; Hsu KC
N Engl J Med; 2012 Aug; 367(9):805-16. PubMed ID: 22931314
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphism analysis of killer cell immunoglobulin-like receptor genes in the Chinese Uygur population.
Wang HD; Zhu BF; Shen CM; Yuan GL; Yang G; Guo JN; Yan JW; Qin HX; Guo JX; Zhang LP; Jia XQ; Lucas R
Mol Biol Rep; 2012 Mar; 39(3):3017-28. PubMed ID: 21701829
[TBL] [Abstract][Full Text] [Related]
16. Report From the First and Second Spanish Killer Immunoglobulin-Like Receptor Genotyping Workshops: External Quality Control for Natural Killer Alloreactive Donor Selection in Haploidentical Stem Cell Transplantation.
Planelles D; Vilches C; González-Escribano F; Muro M; González-Fernández R; Sánchez F; Gonzalo Ocejo J; Eiras A; Caro JL; Palou E; Campillo JA; de Juan MD; Montes O; Balas A; Marín L; Torío A; Fernández-Arquero M; González-Roiz C; López-Vázquez A; Cisneros E; Abad-Molina C; López R; Abad-Alastruey ML; Serra C; García-Alonso AM; Vicario JL
Transplant Proc; 2016 Nov; 48(9):3043-3045. PubMed ID: 27932143
[TBL] [Abstract][Full Text] [Related]
17. Distribution of the killer cell immunoglobulin-like receptors in Mexican Mestizos.
Contreras G; Aláez C; Murguía A; García D; Flores H; Gorodezky C
Tissue Antigens; 2007 Apr; 69 Suppl 1():125-9. PubMed ID: 17445185
[TBL] [Abstract][Full Text] [Related]
18. Donor Killer Immunoglobulin-Like Receptor Profile Bx1 Imparts a Negative Effect and Centromeric B-Specific Gene Motifs Render a Positive Effect on Standard-Risk Acute Myeloid Leukemia/Myelodysplastic Syndrome Patient Survival after Unrelated Donor Hematopoietic Stem Cell Transplantation.
Bao X; Wang M; Zhou H; Zhang H; Wu X; Yuan X; Li Y; Wu D; He J
Biol Blood Marrow Transplant; 2016 Feb; 22(2):232-239. PubMed ID: 26371372
[TBL] [Abstract][Full Text] [Related]
19. Role of Donor Activating KIR-HLA Ligand-Mediated NK Cell Education Status in Control of Malignancy in Hematopoietic Cell Transplant Recipients.
Nowak J; Kościńska K; Mika-Witkowska R; Rogatko-Koroś M; Mizia S; Jaskuła E; Polak M; Mordak-Domagała M; Lange J; Gronkowska A; Jędrzejczak WW; Kyrcz-Krzemień S; Markiewicz M; Dzierżak-Mietła M; Tomaszewska A; Nasiłowska-Adamska B; Szczepiński A; Hałaburda K; Hellmann A; Czyż A; Gil L; Komarnicki M; Wachowiak J; Barańska M; Kowalczyk J; Drabko K; Goździk J; Wysoczańska B; Bogunia-Kubik K; Graczyk-Pol E; Witkowska A; Marosz-Rudnicka A; Nestorowicz K; Dziopa J; Szlendak U; Warzocha K; Lange A;
Biol Blood Marrow Transplant; 2015 May; 21(5):829-39. PubMed ID: 25617806
[TBL] [Abstract][Full Text] [Related]
20. [Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].
Wang H; Zhai WJ; Wang HH; He Y; Zhou Z; Zhao YX; Zhai WH; Zhang RL; Wang M; Feng SZ; Han MZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Oct; 31(5):533-7. PubMed ID: 19968064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
